Lv11
30 积分 2025-02-08 加入
Selumetinib for advanced medullary thyroid carcinoma: phase II study
7小时前
求助中
Multikinase and highly selective kinase inhibitors in the neoadjuvant treatment of patients with thyroid cancer
7小时前
已完结
尼洛替尼治疗中国 KIT 突变型晚期肢端和黏膜黑色素瘤的临床研究
3个月前
已关闭
Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406)
4个月前
已完结
Topical Trametinib for Agminated Spitz Nevi Harboring HRAS Mutation
4个月前
已完结
Characterization of 164 patients with NRAS mutated non-small cell lung cancer (NSCLC)
1年前
已完结
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors
1年前
已完结
皖公网安备34019202002308
